Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies announced a $1.2 billion expansion of its biopharmaceutical manufacturing plant in Holly Springs, North Carolina, adding 680 jobs. The expansion is expected to come online early in 2028.

Fujifilm Diosynth Biotechnologies completed a billion-dollar construction project in Hillerød, Denmark. The expansion is expected to become operational later in 2024 after equipment testing.

Fujifilm Diosynth Biotechnologies broke ground on a $300 million expansion of its vaccine manufacturing campus in College Station, Texas. The project will add 138,000 square feet and double the site's single-use medical device manufacturing capacity.